Business Standard

SPONSORED CONTENT

What's this ?

Sponsored Content is a "Paid For" Press Release distribution arrangement. Purely a Commercial Arrangement, brands and advertisers pay to be featured and to get this content published.

The Editorial/Content team at Business Standard has not contributed to writing/editing this article.

To get your brand featured in this Section write to assist@bsmail.in

Build respiratory immunity with robust product from Nisarga Herbs, Respirade

ANI Press Release 

Tennis player James Blake
Photo: nisargaherbs.com

Mumbai (Maharashtra) [India], October 13 (ANI/PRNewswire): Nisarga Herbs, one of India's leading Ayurveda brands, has launched yet another respiratory immunity building product - Respirade. The newly launched Respirade is a strategic addition to the existing category of respiratory health and immunity boosting product pipeline by the brand.

The innovative ayurvedic formulation made with cutting edge full spectrum technology is effective in the cases of recurring respiratory infections as well as to build a solid preventive support for respiratory health. It is a combination of extracts of Neem (which is currently under trial at ESIC Medical college and hospital Faridabad), Andrographis, Guduchi, Tulsi, Yashtimadhu, Amla and Long pepper.

"We were actually working on this product before the pandemic struck and have administered the tablet twice a day to over 300 employees, their families and the companies around us for the last 6 months. We tested the employees with IgG test and found that 10% of employees showed antibodies developed in them. None of them showed any moderate or severe symptoms and rest 90 per cent have tested negative for IgG antibodies meaning they have not been infected at all. This also means that the symptoms in 10 per cent cases were so mild that no other medication was necessary," said Girish Soman, Founder, Chairman and CEO of Nisarga Biotech Private Limited, while talking about the key benefits of the newly launched product.

The Respirade tablets are specifically formulated to boost respiratory immunity and works best in conditions like Influenza, Asthma and Bronchitis. Its anti-inflammatory action reduces infection and fever due to seasonal changes and it also helps to enhance the preventive support system for respiratory health. The product is very effective for people undergoing Bronchospasm, cough, sore throat, nasal congestion, headache due to cold, low grade fever and all kinds of respiratory infections. Respirade is available in a pack of 30, 60 and 500 tablets at the price points of Rs 190/-, Rs 360/- and Rs 2,500/-, respectively. One can buy the product on Nisarga Herbs official website and the product is also available on several online aggregating platforms like Amazon.

Nisarga Herbs has always been a step ahead and introduced several effective, price competitive and quality Ayurveda led health products over the years. It is also India's first Ayurveda company to collaborate with All India Institute of Ayurveda (AIIA) to conduct India's first Neem formulation led double-blind, randomized, placebo-controlled trial on frontline medical staff in prevention of COVID-19 at ESIC Medical College and Hospital, Faridabad.The trial is ongoing on 250 frontline medical and non-medical staff at ESIC Hospital, Faridabad and has till date shown positive progress. 244 patients have been enrolled so far and 161 have begun taking the products. The rest are waiting for initial lab test results before dosing can begin. The result of this clinical trial is expected by the end of November.

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, October 13 2020. 20:00 IST
RECOMMENDED FOR YOU

Build respiratory immunity with robust product from Nisarga Herbs, Respirade

Mumbai (Maharashtra) [India], October 13 (ANI/PRNewswire): Nisarga Herbs, one of India's leading Ayurveda brands, has launched yet another respiratory immunity building product - Respirade. The newly launched Respirade is a strategic addition to the existing category of respiratory health and immunity boosting product pipeline by the brand.

Mumbai (Maharashtra) [India], October 13 (ANI/PRNewswire): Nisarga Herbs, one of India's leading Ayurveda brands, has launched yet another respiratory immunity building product - Respirade. The newly launched Respirade is a strategic addition to the existing category of respiratory health and immunity boosting product pipeline by the brand.

The innovative ayurvedic formulation made with cutting edge full spectrum technology is effective in the cases of recurring respiratory infections as well as to build a solid preventive support for respiratory health. It is a combination of extracts of Neem (which is currently under trial at ESIC Medical college and hospital Faridabad), Andrographis, Guduchi, Tulsi, Yashtimadhu, Amla and Long pepper.

"We were actually working on this product before the pandemic struck and have administered the tablet twice a day to over 300 employees, their families and the companies around us for the last 6 months. We tested the employees with IgG test and found that 10% of employees showed antibodies developed in them. None of them showed any moderate or severe symptoms and rest 90 per cent have tested negative for IgG antibodies meaning they have not been infected at all. This also means that the symptoms in 10 per cent cases were so mild that no other medication was necessary," said Girish Soman, Founder, Chairman and CEO of Nisarga Biotech Private Limited, while talking about the key benefits of the newly launched product.

The Respirade tablets are specifically formulated to boost respiratory immunity and works best in conditions like Influenza, Asthma and Bronchitis. Its anti-inflammatory action reduces infection and fever due to seasonal changes and it also helps to enhance the preventive support system for respiratory health. The product is very effective for people undergoing Bronchospasm, cough, sore throat, nasal congestion, headache due to cold, low grade fever and all kinds of respiratory infections. Respirade is available in a pack of 30, 60 and 500 tablets at the price points of Rs 190/-, Rs 360/- and Rs 2,500/-, respectively. One can buy the product on Nisarga Herbs official website and the product is also available on several online aggregating platforms like Amazon.

Nisarga Herbs has always been a step ahead and introduced several effective, price competitive and quality Ayurveda led health products over the years. It is also India's first Ayurveda company to collaborate with All India Institute of Ayurveda (AIIA) to conduct India's first Neem formulation led double-blind, randomized, placebo-controlled trial on frontline medical staff in prevention of COVID-19 at ESIC Medical College and Hospital, Faridabad.The trial is ongoing on 250 frontline medical and non-medical staff at ESIC Hospital, Faridabad and has till date shown positive progress. 244 patients have been enrolled so far and 161 have begun taking the products. The rest are waiting for initial lab test results before dosing can begin. The result of this clinical trial is expected by the end of November.

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
image
Business Standard
177 22

Build respiratory immunity with robust product from Nisarga Herbs, Respirade

Mumbai (Maharashtra) [India], October 13 (ANI/PRNewswire): Nisarga Herbs, one of India's leading Ayurveda brands, has launched yet another respiratory immunity building product - Respirade. The newly launched Respirade is a strategic addition to the existing category of respiratory health and immunity boosting product pipeline by the brand.

The innovative ayurvedic formulation made with cutting edge full spectrum technology is effective in the cases of recurring respiratory infections as well as to build a solid preventive support for respiratory health. It is a combination of extracts of Neem (which is currently under trial at ESIC Medical college and hospital Faridabad), Andrographis, Guduchi, Tulsi, Yashtimadhu, Amla and Long pepper.

"We were actually working on this product before the pandemic struck and have administered the tablet twice a day to over 300 employees, their families and the companies around us for the last 6 months. We tested the employees with IgG test and found that 10% of employees showed antibodies developed in them. None of them showed any moderate or severe symptoms and rest 90 per cent have tested negative for IgG antibodies meaning they have not been infected at all. This also means that the symptoms in 10 per cent cases were so mild that no other medication was necessary," said Girish Soman, Founder, Chairman and CEO of Nisarga Biotech Private Limited, while talking about the key benefits of the newly launched product.

The Respirade tablets are specifically formulated to boost respiratory immunity and works best in conditions like Influenza, Asthma and Bronchitis. Its anti-inflammatory action reduces infection and fever due to seasonal changes and it also helps to enhance the preventive support system for respiratory health. The product is very effective for people undergoing Bronchospasm, cough, sore throat, nasal congestion, headache due to cold, low grade fever and all kinds of respiratory infections. Respirade is available in a pack of 30, 60 and 500 tablets at the price points of Rs 190/-, Rs 360/- and Rs 2,500/-, respectively. One can buy the product on Nisarga Herbs official website and the product is also available on several online aggregating platforms like Amazon.

Nisarga Herbs has always been a step ahead and introduced several effective, price competitive and quality Ayurveda led health products over the years. It is also India's first Ayurveda company to collaborate with All India Institute of Ayurveda (AIIA) to conduct India's first Neem formulation led double-blind, randomized, placebo-controlled trial on frontline medical staff in prevention of COVID-19 at ESIC Medical College and Hospital, Faridabad.The trial is ongoing on 250 frontline medical and non-medical staff at ESIC Hospital, Faridabad and has till date shown positive progress. 244 patients have been enrolled so far and 161 have begun taking the products. The rest are waiting for initial lab test results before dosing can begin. The result of this clinical trial is expected by the end of November.

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22